Breast imaging: A survey
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Breast cancer is the second leading cause of death in women. It occurs when cells in the breast start to grow out of proportion and invade neighboring tissues or spread throughout the body. Mammography is one of the most effective and popular modalities presently used for breast cancer screening and detection. Efforts have been made to improve the accuracy of breast cancer diagnosis using different imaging modalities. Ultrasound and magnetic resonance imaging have been used to detect breast cancers in high risk patients. Recently, electrical impedance imaging and nuclear medicine techniques are also being widely used for breast cancer screening and diagnosis. In this paper, we discuss the capabilities of various breast imaging modalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
Initial in vivo experience with steady‐state subzone‐based MR elastography of the human breast
Van Houten, E. E. W., Doyley, M. M., Kennedy, F. E., Weaver, J. B., & Paulsen, K. D. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10232 · Cited by 224
Biomarkers for early detection of breast cancer: What, when, and where?
LEVENSON, V (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.017 · Cited by 131
Cited by
Celik, Y., Talo, M., Yildirim, O., Karabatak, M., & Acharya, U. R. (2020) · Pattern Recognition Letters · doi:10.1016/j.patrec.2020.03.011 · Cited by 318
Metadata
- Authors
- Sree, S. V.
- Venue
- World Journal of Clinical Oncology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2011
- Volume
- 2
- Issue
- 4
- Pages
- 171
- ISSN
- 2218-4333 (ISSN-L)
- OpenAlex
- W2097802970
- Cited by
- 158
- References
- 3
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.